Mbarara Acute Heart Failure Registry

Mbarara Acute Heart Failure Registry: Opportunities to Improve Care of Patients Hospitalized With Acute Decompensated Heart Failure in Mbarara Regional Referral Hospital, Uganda

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02721030

Acronym

MAHFER

Enrollment

217

Registered

2016-03-28

Start date

2016-03-01

Completion date

2018-03-23

Last updated

2018-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heartfailure

Keywords

Heartfailure, 1-year mortality, heartfailure quality of life, sub-Saharan Africa

Brief summary

This is a prospective cohort to describe clinical characteristics, predictors of poor outcomes both during hospitalization and at home, functional status, and quality of life among patients aged 13 years or more, consecutively admitted with acute decompensated heart failure at Mbarara Regional Referral Hospital.

Detailed description

This is a prospective observational cohort study to collect comprehensive data of heartfailure patients during and after hospitalization for acute heart failure at Mbarara Regional Referral Hospital (MRRH), Uganda. The investigators will collect sociodemographic, clinical, quality of life, functional status, and clinical cardiovascular disease measures during hospitalization and follow up for up to 1 year from the date of enrollment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

13 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients admitted with a confirmed clinical diagnosis of acute heartfailure aged 13 years or above at Mbarara Regional Referral Hospital, Uganda

Exclusion criteria

* Body swelling from kidney disease, liver disease or malnutrition. * Acute kidney disease with no previous history/documentation of heart disease. * History suggestive of chronic kidney disease with no previous history/documentation of heart disease. * History suggestive of chronic liver disease with no previous history/documentation of heart disease.

Design outcomes

Primary

Measure	Time frame
All-cause mortality	1 year

Secondary

Measure	Time frame	Description
Length of hospitalization	1 year	Length of hospital stay
Quality of life using the SF-36 questionnaire	1 year	Quality of life will be measured using SF-36 questionnaire.
Functional status using the Kansas city cardiomyopathy questionnaire	1 year	Kansas city cardiomyopathy questionnaire will be used to measure functional status during hospitalization and quarterly after hospitalization with acute heartfailure.

Countries

Uganda

Outcome results